BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 17131414)

  • 21. Consensus conference on well-differentiated thyroid cancer: a summary.
    Pasieka JL; Rotstein LE
    Can J Surg; 1993 Aug; 36(4):298-301. PubMed ID: 8370008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors in follicular carcinoma of the thyroid: a study of 198 cases.
    Rao RS; Parikh HK; Deshmane VH; Parikh DM; Shrikhande SS; Havaldar R
    Head Neck; 1996; 18(2):118-24; discussion 124-6. PubMed ID: 8647676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extent of thyroidectomy is not a major determinant of survival in low- or high-risk papillary thyroid cancer.
    Haigh PI; Urbach DR; Rotstein LE
    Ann Surg Oncol; 2005 Jan; 12(1):81-9. PubMed ID: 15827782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of surgical treatment results in patients with differentiated thyroid cancer from materials in the Oncologic Institute in Gliwice].
    Włoch J; Czarniecka A; Turska M; Wilgus J
    Wiad Lek; 2001; 54 Suppl 1():178-88. PubMed ID: 12182023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
    Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
    Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Differentiated thyroid carcinoma in children and adolescents: therapeutic strategy according to clinic presentation].
    Causeret S; Lifante JC; Borson-Chazot F; Varcus F; Berger N; Peix JL
    Ann Chir; 2004; 129(6-7):359-64. PubMed ID: 15297226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Well-differentiated thyroid carcinoma: factors predicting recurrence and survival.
    Lim LH; Soo KC; Chong YK; Gao F; Hong GS; Lim TH
    Singapore Med J; 2002 Sep; 43(9):457-62. PubMed ID: 12568423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems.
    Yildirim E
    J Am Coll Surg; 2005 Mar; 200(3):378-92. PubMed ID: 15737848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors in well-differentiated thyroid carcinoma.
    Cushing SL; Palme CE; Audet N; Eski S; Walfish PG; Freeman JL
    Laryngoscope; 2004 Dec; 114(12):2110-5. PubMed ID: 15564829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [How good is the prognosis in differentiated thyroid gland carcinoma].
    Ommer A; Bottel P; Stremmel W
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():192-5. PubMed ID: 9101828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of thyroid cancer based on risk groups.
    Shaha A
    J Surg Oncol; 2006 Dec; 94(8):683-91. PubMed ID: 17131422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
    McCaffrey JC
    Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conservative management of patients with intrathyroidal well-differentiated follicular thyroid carcinoma.
    Saadi H; Kleidermacher P; Esselstyn C
    Surgery; 2001 Jul; 130(1):30-5. PubMed ID: 11436009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of locally aggressive well-differentiated thyroid cancer.
    Martins AS; Melo GM; Valério JB; Langner E; Lage HT; Tincani AJ
    Int Surg; 2001; 86(4):213-9. PubMed ID: 12056464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma.
    Zaydfudim V; Feurer ID; Griffin MR; Phay JE
    Surgery; 2008 Dec; 144(6):1070-7; discussion 1077-8. PubMed ID: 19041020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiated thyroid cancer and outcome in iodine deficiency.
    Gyory F; Balazs G; Nagy EV; Juhasz F; Mezosi E; Szakall S; Math J; Lukacs G
    Eur J Surg Oncol; 2004 Apr; 30(3):325-31. PubMed ID: 15028317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Follicular and Hürthle cell carcinoma: predicting outcome and directing therapy.
    Sanders LE; Silverman M
    Surgery; 1998 Dec; 124(6):967-74. PubMed ID: 9854570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment for microcarcinoma of the thyroid--clinical experience.
    Küçük NO; Tari P; Tokmak E; Aras G
    Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The survival rate of patients with a differentiated thyroid carcinoma without primary percutaneous irradiation of the neck area].
    Saur HB; Lerch H; Schober O
    Strahlenther Onkol; 1996 Jun; 172(6):306-11. PubMed ID: 8677502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiated and medullary thyroid cancer in childhood and adolescence.
    La Quaglia MP; Telander RL
    Semin Pediatr Surg; 1997 Feb; 6(1):42-9. PubMed ID: 9117274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.